Clinical Trial Update: Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intermediate or prophylactic-dose anticoagulation to prevent venous or arterial thromboembolism in adults with severe COVID-19. The res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thrombosis
• Venous Thromboembolism

Snippet

Sponsor: Columbia University | Conditions: COVID-19, Venous Thromboses | Phase 4 | Status: COMPLETED | Results posted: 2024-12-10